Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies

PURPOSE: Subcutaneous allergen-specific immunotherapy (SCIT) is a well-established and clinically effective method to treat allergic diseases, such as rhinitis and asthma. It remains unclear how soon after initiation of an ultra-short course of grass pollen immunotherapy adjuvanted with monophosphor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosewich, Martin, Girod, Katharina, Zielen, Stefan, Schubert, Ralf, Schulze, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773214/
https://www.ncbi.nlm.nih.gov/pubmed/26922936
http://dx.doi.org/10.4168/aair.2016.8.3.257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773214/
https://www.ncbi.nlm.nih.gov/pubmed/26922936
http://dx.doi.org/10.4168/aair.2016.8.3.257

Ejemplares similares